483 Eli Lilly & Company Jan 2002

483 Eli Lilly & Company Jan 2002

Patricia Dlugosz FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly & Company - Indianapolis, IN, United States facility and issued inspectional observations (via FDA 483) on 11 Jan 2002.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Jan 2002
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart